UAMS News describes an Interventional Psychiatry program using MRI-guided targeting to deliver precise transcranial magnetic stimulation for major depression.
UAMS program description
UAMS News reports that UAMS’s Psychiatric Research Institute describes an Interventional Psychiatry program. According to UAMS News, the program was the first in the country to offer the SAINT neuromodulation system. The source identifies major depression as the condition discussed in connection with the system and its use of transcranial magnetic stimulation.
UAMS News presents the information as a description of the institute’s Interventional Psychiatry program. The extract does not describe a legislative change, insurance policy, or statewide treatment initiative. It focuses on the program and the neuromodulation system it offers.
MRI-guided targeting
According to UAMS News, the SAINT neuromodulation system uses MRI-guided targeting. The source says this targeting is used to deliver precise transcranial magnetic stimulation for major depression.
The UAMS News extract does not provide further detail on how MRI-guided targeting is performed. It also does not describe treatment schedules, the length of a treatment course, or what steps may be involved before someone receives treatment. The source’s stated description is limited to MRI-guided targeting and transcranial magnetic stimulation for major depression.
Information not included in the extract
UAMS News does not provide patient outcome data in the supplied extract. The extract does not state who may be eligible for the program, whether referrals are needed, or how patients are assessed. It also does not address insurance coverage, costs, appointment availability, or travel arrangements.
The source does not compare the SAINT neuromodulation system with other approaches to transcranial magnetic stimulation. It does not state whether the program is available to every person with major depression or describe decisions about individual treatment. UAMS News identifies the system’s MRI-guided targeting as the feature used to deliver precise transcranial magnetic stimulation.
What this means for Arkansas patients
For people seeking treatment locally, the UAMS News report identifies an Arkansas program describing MRI-guided targeting for transcranial magnetic stimulation in major depression. The directory lists 32 published clinics in Arkansas, which may help readers locate treatment options in the state.
The supplied UAMS News extract does not provide practical details about accessing the described program. General information only; this is not medical advice.
More Arkansas reporting on treatment updates.
This report is educational and is not medical advice. Coverage, availability and eligibility can change; verify details with the named source or your care team.